BioPharma Credit PLC (BPCR) — Financial Flexibility Index
BioPharma Credit PLC (BPCR) has a Financial Flexibility Index of 4.50x as of June 2025. Free cash flow of $33.76 Million (operating CF $33.76 Million minus capex $0.00) represents 5% of total liabilities ($7.49 Million). Check BPCR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioPharma Credit PLC Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for BioPharma Credit PLC across 8 annual periods. For the full cash flow conversion analysis, see BioPharma Credit PLC cash flow conversion.
Annual Financial Flexibility Index for BioPharma Credit PLC (2017–2024)
Year-by-year free cash flow to debt coverage for BioPharma Credit PLC. Explore BPCR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 6.24x | $111.91 Million | $111.91 Million | $17.94 Million | ▼ -19.6% |
| 2023 | 7.76x | $123.18 Million | $123.18 Million | $15.87 Million | ▲ +10.8% |
| 2022 | 7.01x | $184.28 Million | $184.28 Million | $26.30 Million | ▼ -49.9% |
| 2021 | 13.98x | $96.44 Million | $96.44 Million | $6.90 Million | ▲ +126.1% |
| 2020 | 6.18x | $58.07 Million | $58.07 Million | $9.39 Million | ▲ +18.6% |
| 2019 | 5.21x | $131.52 Million | $131.52 Million | $25.23 Million | ▲ +2.9% |
| 2018 | 5.07x | $67.14 Million | $67.14 Million | $13.25 Million | ▼ -36.0% |
| 2017 | 7.91x | $23.07 Million | $23.07 Million | $2.92 Million | — |